Zhong Yuan Bio-Technology Holdings Limited
ZHYBF · OTC
3/31/2024 | 3/31/2023 | 3/31/2022 | 3/31/2021 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | 37% | -28.6% | 42.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 90.9% | 91.3% | 82% | 82.8% |
| EBITDA | $0 | -$0 | -$0 | $0 |
| % Margin | 20.9% | -88.5% | -19.5% | 10.9% |
| Net Income | $0 | -$0 | -$0 | -$0 |
| % Margin | 13.3% | -134.2% | -48.3% | -1.7% |
| EPS Diluted | 0.017 | -0.12 | -0.065 | -0.002 |
| % Growth | 114% | -84.3% | -3,968.8% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | $0 |
| Capital Expenditures | $0 | -$0 | $0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | $0 |